Q4 EPS Estimates for Verona Pharma Lowered by HC Wainwright
Verona Pharma plc (NASDAQ:VRNA – Free Report) – Research analysts at HC Wainwright dropped their Q4 2025 EPS estimates for Verona Pharma in a report issued on Wednesday, April 30th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings of $0.02 per share for the quarter, down from their previous estimate […]
Verona Pharma plc (NASDAQ:VRNA – Free Report) – Research analysts at HC Wainwright dropped their Q4 2025 EPS estimates for Verona Pharma in a report issued on Wednesday, April 30th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings of $0.02 per share for the quarter, down from their previous estimate […]
